Murat Gunel
Directeur/Membre du Conseil chez AI Therapeutics, Inc.
Profil
Murat Gunel currently works at OrphAI Therapeutics, Inc., as Director and 4 Catalyzer Corp., as Advisor.
Postes actifs de Murat Gunel
| Sociétés | Poste | Début |
|---|---|---|
4 Catalyzer Corp.
 4 Catalyzer Corp. Investment ManagersFinance 4 Catalyzer Corporation (4 Catalyzer Corp.) is a venture capital firm founded in 2014 by Jonathan M. Rothberg. The firm is headquartered in Guilford, Connecticut. | Consultant / Advisor | - |
AI Therapeutics, Inc.
 AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
4 Catalyzer Corp.
4 Catalyzer Corp. Investment ManagersFinance 4 Catalyzer Corporation (4 Catalyzer Corp.) is a venture capital firm founded in 2014 by Jonathan M. Rothberg. The firm is headquartered in Guilford, Connecticut. | Finance |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Health Technology |
